scispace - formally typeset
M

Matej Orešič

Researcher at Örebro University

Publications -  390
Citations -  32818

Matej Orešič is an academic researcher from Örebro University. The author has contributed to research in topics: Medicine & Lipid metabolism. The author has an hindex of 82, co-authored 352 publications receiving 26830 citations. Previous affiliations of Matej Orešič include University of Iceland & University of Turku.

Papers
More filters
Journal ArticleDOI

Elevated pro-inflammatory and lipotoxic mucosal lipids characterise irritable bowel syndrome

TL;DR: IBS mucosa is characterised by a distinct pro-inflammatory and lipotoxic metabolic profile, and there was an increase in several lipid species such as lysophospholipids and ceramides.
Journal ArticleDOI

The gut microbiota modulates glycaemic control and serum metabolite profiles in non-obese diabetic mice.

TL;DR: The data suggest that germ-free NOD mice have reduced glycaemic control and dysregulated immunologic and metabolic responses, which are similar to that of pre-diabetic children.
Journal ArticleDOI

Metabolic transformations of dietary polyphenols: comparison between in vitro colonic and hepatic models and in vivo urinary metabolites.

TL;DR: Comparing in vitro microbial phenolic metabolite profile of foods and beverages with that excreted in urine of subjects consuming the same foodstuff and exploring the role of liver on postcolonic metabolism of polyphenols by using in vitro hepatic models may better elucidate the metabolism ofpolyphenols from dietary exposure to urinary metabolites.
Journal ArticleDOI

15-Hydroxyprostaglandin dehydrogenase associates with poor prognosis in breast cancer, induces epithelial-mesenchymal transition, and promotes cell migration in cultured breast cancer cells.

TL;DR: HPGD mRNA is overexpressed in a subset of clinical breast cancers compared to normal breast tissue samples and that high HPGD mRNA expression associates with poor prognosis, and results indicate that HPGD is highly expressed in metastatic and aggressive breast cancer and promotes EMT and migration in breast cancer cells.